FeesSafety
Pluang+

Simpson Manufacturing boosts share buyback plan to $1 billion with no expiration date

Company Fundamentals
26 Oct 2026, 23:16 WIB
PRNewsWire
View Source
Bullish
Simpson Manufacturing boosts share buyback plan to $1 billion with no expiration date

Simpson Manufacturing Co., Inc. has increased its share repurchase authorization from $200 million to $1 billion, effective October 22, 2026, with no expiration date. This move reflects the company's confidence in its long-term strategy and strong financial position, allowing flexibility to return capital to shareholders. The company repurchased about $165 million of stock under the previous plan this year. Future repurchases will depend on market conditions and capital priorities, but there is no obligation to buy a specific amount of shares.

Simpson Manufacturing Co., Inc.'s new $1.0 billion share repurchase authorization is noted here with Pluang's Industrials sector data as of Oct 27, 2026 03:01 WIB. Of 135 priced US Industrials stocks on Pluang, 85 rose and 49 fell today. Notable movers include PAYX at USD 118.62 with a 5.44% increase and a typical hold time of 56 days, and GEV at USD 857.93 with a 5.27% gain and 58% buy order activity. The most notable figure is PAYX's 5.44% daily price increase.

More News

Exodus Movement to announce Q3 2026 financial results on Nov 9 with a webcast.

Exodus Movement to announce Q3 2026 financial results on Nov 9 with a webcast.

Exodus Movement, a self-custodial finance and payments platform, will release its third quarter 2026 financial results after market close on November 9, 2026. The company will host a webcast at 5:00 PM ET the same day to discuss the results. Founded ...

Company Fundamentals
Neutral
1 hour ago
Onco360 named national pharmacy partner for AstraZeneca's lung cancer drug Zegfrovy.

Onco360 named national pharmacy partner for AstraZeneca's lung cancer drug Zegfrovy.

Onco360, a leading independent specialty pharmacy, has been selected by AstraZeneca as a national pharmacy partner for Zegfrovy (sunvozertinib), a treatment for advanced non-small cell lung cancer with EGFR exon 20 insertion mutations. Zegfrovy has s...

Market News
Bullish
1 hour ago
S4A IT Solutions joins SAP PartnerEdge program, boosting its SAP consulting capabilities.

S4A IT Solutions joins SAP PartnerEdge program, boosting its SAP consulting capabilities.

S4A IT Solutions has been accepted into the SAP PartnerEdge program, marking a key milestone in its growth. This partnership enhances S4A's ability to help organizations maximize their SAP investments, especially in areas like asset management and su...

Market News
Bullish
2 hours ago
SEC policy shifts and rising shareholder activism shape 2027 proxy season preparations for public companies

SEC policy shifts and rising shareholder activism shape 2027 proxy season preparations for public companies

Public companies are facing new challenges for the 2027 proxy season due to changes in SEC policies, evolving shareholder activism strategies, and shifts in institutional investor voting. A virtual roundtable on October 28 will gather experts to disc...

Market News
Neutral
3 hours ago
Gogo to release Q3 2026 earnings on Nov 6 with a conference call for analysts.

Gogo to release Q3 2026 earnings on Nov 6 with a conference call for analysts.

Gogo Inc., a leading provider of in-flight broadband connectivity, announced it will report its third quarter 2026 financial results on November 6, 2026, before the market opens. The company will hold a conference call with financial analysts the sam...

Company Fundamentals
Neutral
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App